REDFILED (Page 5)

Cosentyx is aimed at adults with polymyalgia rheumatica who relapse as steroids are tapered.

NVS

NOVARTIS (NVS) Wins Positive CHMP Opinion for Cosentyx in Polymyalgia Rheumatica

The EMA committee recommends Cosentyx for adults with PMR who fail steroids, which would make it the first IL-17A inhibitor cleared for the disease in Europe.

A dispute over a sold life insurance portfolio has moved to the US courts.

Regulatory

RESS LIFE INVESTMENTS Sues Buyer of Life Portfolio Over $129M Earn-Out

The Danish fund has terminated the sale of its legacy life insurance portfolio and filed US court complaints alleging fraud and breach of contract.

FFAI

FARADAY FUTURE (FFAI) Cuts Convertible Note Payoff to $5.9M in Amendment

Faraday Future can settle a senior convertible note with $9.33M outstanding by paying $5.88M within six months, and interest stops accruing.

KLXE

KLX ENERGY (KLXE) Reminds Holders $125M Rights Offering Expires September 23

The oilfield services firm's backstopped rights offering, priced at $1.49 per share, closes at 5:00 pm New York time on September 23, 2026.

Nauticus Robotics develops autonomous subsea robots for offshore work.

KITT

NAUTICUS ROBOTICS (KITT) Pushes Term Loan Maturity to January 2028

The subsea robotics firm's lenders agreed to extend its senior secured term loan by more than 16 months and waived maturity-related defaults, with no extension fee.

Bill Smith, founder of Smith Micro Software, has returned as president and chief executive officer.

SMSI

SMITH MICRO (SMSI) Founder Bill Smith Returns as President and CEO

Smith Micro said founder Bill Smith has retaken the CEO role six months after stepping back, succeeding Tim Huffmyer, who resigned but stays on the board.

Research into hypertrophic cardiomyopathy focuses on how the heart muscle thickens.

BMY

BRISTOL-MYERS SQUIBB (BMY) Halts Phase 3 Mavacamten Trial for Lack of Efficacy

The company terminated its Phase 3 study of mavacamten in non-obstructive hypertrophic cardiomyopathy after the drug failed to show short-term efficacy.

A product tanker under way, the type of vessel operated by Scorpio Tankers.

STNG

SCORPIO TANKERS (STNG) Secretary Sells Entire $613K Stake

Company secretary Auste Adelborg sold 6,834 Scorpio Tankers shares at $89.64 apiece on 17 September, leaving no direct holding.

ABEO

FDA Approval of Ultragenyx Gene Therapy Triggers ABEONA Royalties

Abeona is eligible for commercial milestone payments and royalties after the FDA approved FAYUVI, the Sanfilippo type A gene therapy it out-licensed in 2022.

CAVA

CAVA Approves $100 Million Share Repurchase Program

The Mediterranean fast-casual chain's board authorized buybacks of up to $100 million, funded from cash on hand and operating cash flow, through September 2027.

Rukmini Sivaraman, an executive at Nutanix.

NTNX

NUTANIX (NTNX) Insider Sivaraman Sells $2.7M in Stock After Option Exercises

A Form 4 shows Rukmini Sivaraman sold 38,139 Nutanix Class A shares at $70.002 on 17 September, leaving 325,487 shares held.

Palantir's data analytics software is used by government and commercial clients.

PLTR

PALANTIR (PLTR) Director Alexander Moore Sells $2.8M in Class A Stock

Board member Alexander D. Moore sold 16,000 Palantir Class A shares on 15 September at prices between $170.26 and $176.11, a Form 4 shows.

Latest